BACKGROUND: Apolipoprotein E (apoE), a component of plasma lipoproteins, plays an important, but poorly defined role in sepsis. We have shown that injecting apoE increases septic mortality in a rat model of gram-negative bacterial sepsis, with concomitant hepatic natural killer T (NKT) cell proliferation and activation. The presumed mechanism for this apoE-mediated mortality is that apoE can bind and traffic antigens, presumed to include lipopolysaccharide (LPS), and promote activation of dendritic cells (DC) with subsequent NKT activation and cytokine release. Thus, we sought to prove that LPS was the antigen responsible for the increased NKT activation enhanced by the presence of apoE. METHODS: We isolated murine marrow-derived DCs, pulsed them with lipid antigen (LPS, and positive controls alpha-galactosylceramide [alpha-GalCer] and isoglobotrihexosylceramide 3 [iGb3]) with or without apoE, and then cocultured the DCs with hybridoma NKTs. NKT activation was measured by interleukin-2 (IL-2) supernatant levels using enzyme-linked immunosorbent assay (ELISA). RESULTS: LPS at different concentrations was a weak stimulus for NKT activation regardless of apoE presence. When apoE was present, iGb3, an endogenous ligand analog, elicited more than a 2-fold increase in IL-2 response when compared with iGb3 alone (P < .05). CONCLUSIONS: These results indicate an endogenous ligand, not LPS, may be responsible for NKT activation. A molecular remnant similar to iGb3 could act as a damage-associated molecular pattern and play a prominent role in animal models of sepsis. 2010 Elsevier Inc. All rights reserved.
BACKGROUND:Apolipoprotein E (apoE), a component of plasma lipoproteins, plays an important, but poorly defined role in sepsis. We have shown that injecting apoE increases septic mortality in a rat model of gram-negative bacterial sepsis, with concomitant hepatic natural killer T (NKT) cell proliferation and activation. The presumed mechanism for this apoE-mediated mortality is that apoE can bind and traffic antigens, presumed to include lipopolysaccharide (LPS), and promote activation of dendritic cells (DC) with subsequent NKT activation and cytokine release. Thus, we sought to prove that LPS was the antigen responsible for the increased NKT activation enhanced by the presence of apoE. METHODS: We isolated murine marrow-derived DCs, pulsed them with lipid antigen (LPS, and positive controls alpha-galactosylceramide [alpha-GalCer] and isoglobotrihexosylceramide 3 [iGb3]) with or without apoE, and then cocultured the DCs with hybridoma NKTs. NKT activation was measured by interleukin-2 (IL-2) supernatant levels using enzyme-linked immunosorbent assay (ELISA). RESULTS:LPS at different concentrations was a weak stimulus for NKT activation regardless of apoE presence. When apoE was present, iGb3, an endogenous ligand analog, elicited more than a 2-fold increase in IL-2 response when compared with iGb3 alone (P < .05). CONCLUSIONS: These results indicate an endogenous ligand, not LPS, may be responsible for NKT activation. A molecular remnant similar to iGb3 could act as a damage-associated molecular pattern and play a prominent role in animal models of sepsis. 2010 Elsevier Inc. All rights reserved.
Authors: Or Kalchiem-Dekel; Xianglan Yao; Amisha V Barochia; Maryann Kaler; Debbie M Figueroa; William B Karkowsky; Elizabeth M Gordon; Meixia Gao; Maria M Fergusson; Xuan Qu; Poching Liu; Yuesheng Li; Fayaz Seifuddin; Mehdi Pirooznia; Stewart J Levine Journal: Am J Respir Cell Mol Biol Date: 2020-08 Impact factor: 6.914
Authors: Xianglan Yao; Elizabeth M Gordon; Debbie M Figueroa; Amisha V Barochia; Stewart J Levine Journal: Am J Respir Cell Mol Biol Date: 2016-08 Impact factor: 6.914
Authors: Orleâncio Gomes R Azevedo; Renato André C Oliveira; Bruna Castro Oliveira; Snjezana Zaja-Milatovic; Celina Viana Araújo; Deysi Viviana T Wong; Tiê Bezerra Costa; Herene Barros Miranda Lucena; Roberto César P Lima; Ronaldo A Ribeiro; Cirle A Warren; Aldo Ângelo M Lima; Michael P Vitek; Richard L Guerrant; Reinaldo B Oriá Journal: BMC Gastroenterol Date: 2012-07-13 Impact factor: 3.067
Authors: Ata Murat Kaynar; Sachin Yende; Lin Zhu; Daniel R Frederick; Robin Chambers; Christine L Burton; Melinda Carter; Donna Beer Stolz; Brittani Agostini; Alyssa D Gregory; Shanmugam Nagarajan; Steven D Shapiro; Derek C Angus Journal: Crit Care Date: 2014-09-03 Impact factor: 9.097
Authors: John D Bagdade; Bernd Jilma; Lisa C Hudgins; Petar Alaupovic; Carrie E McCurdy Journal: Lipids Health Dis Date: 2018-05-28 Impact factor: 3.876
Authors: Orleâncio G R Azevedo; David T Bolick; James K Roche; Relana F Pinkerton; Aldo A M Lima; Michael P Vitek; Cirle A Warren; Reinaldo B Oriá; Richard L Guerrant Journal: PLoS One Date: 2014-02-28 Impact factor: 3.240